Loading...

SOHO 2026 Annual Meeting

This website and third-party tools we use rely on cookies for the best user experience. By selecting "I agree", you agree to cookie usage as described in our Privacy Policy.

1,267 posters, 47 videos, 13 topics, 4 sessions, 853 authors

ePostersLive by SciGen Technologies S.A. All rights reserved.

SOHO 2026 Annual Meeting

September 9 - 12, 2026 | George R. Brown Convention Center, Houston, Texas

Home Posters by Code Posters by Title Authors Affiliations Topics Sessions Videos Audios Previous meetings

Topics

Select Topic

Showing 54 results for "Hodgkin Lymphoma (HL)".

Thumbnail for Impact of Alcohol Use Disorder On In-Hospital Outcomes Among Patients Hospitalized With Hodgkin Lymphoma: A National Inpatient Sample Study, 2016-2022

HL - 1226

Impact of Alcohol Use Disorder On In-Hospital Outcomes Among Patients Hospitalized With Hodgkin Lymphoma: A National Inpatient Sample Study, 2016-2022

Amna Shaukat

Poster Presenter: Amna Shaukat

Thumbnail for Nivolumab+AVD versus eBEACOPP in advanced-stage classic Hodgkin lymphoma. Single-center, non-randomized, prospective clinical trial. Real clinical practice.

HL - 1286

Nivolumab+AVD versus eBEACOPP in advanced-stage classic Hodgkin lymphoma. Single-center, non-randomized, prospective clinical trial. Real clinical practice.

Diana Ivanova

Poster Presenter: Diana Ivanova

Previous 1 2 3 4 5 6 Next

Copyright © 2015-2026, ePostersLive® SciGen is a registered trademark of SciGen Technologies S.A. Patent pending.

Thumbnail for Advancement for All? Sociodemographic Predictors of Treatment Receipt as Barriers to Equitable Care in Hodgkin Lymphoma

HL - 1338

Advancement for All? Sociodemographic Predictors of Treatment Receipt as Barriers to Equitable Care in Hodgkin Lymphoma

Mohammed Mahrous

Poster Presenter: Mohammed Mahrous

Thumbnail for Overall Survival Differs by Treatment Setting in Older Adults With Classical Hodgkin Lymphoma: A National Cancer Database Analysis

HL - 1340

Overall Survival Differs by Treatment Setting in Older Adults With Classical Hodgkin Lymphoma: A National Cancer Database Analysis

Nikki Verma

Poster Presenter: Nikki Verma

Thumbnail for PET-GUIDED NIVOLUMAB-BASED FIRST-LINE STRATEGY IN ADVANCED-STAGE CLASSICAL HODGKIN LYMPHOMA: INTERIM CLINICAL RESULTS

HL - 1412

PET-GUIDED NIVOLUMAB-BASED FIRST-LINE STRATEGY IN ADVANCED-STAGE CLASSICAL HODGKIN LYMPHOMA: INTERIM CLINICAL RESULTS

Hunan Julhakyan

Poster Presenter: Hunan Julhakyan

Thumbnail for Total Lesion Glycolysis on Interim PET/CT as a Predictor of Outcomes in Classic Hodgkin Lymphoma With Deauville Score 4-5: A Latin American Retrospective Cohort

HL - 1419

Total Lesion Glycolysis on Interim PET/CT as a Predictor of Outcomes in Classic Hodgkin Lymphoma With Deauville Score 4-5: A Latin American Retrospective Cohort

Andre Meireles

Poster Presenter: Andre Meireles

Thumbnail for Redefining "Safe" Anthracycline Limits: A Restricted Cubic Spline Meta-Analysis of Continuous Cumulative Dosing and Non-Linear Cardiotoxicity in Hodgkin Lymphoma Survivors

HL - 1461

Redefining "Safe" Anthracycline Limits: A Restricted Cubic Spline Meta-Analysis of Continuous Cumulative Dosing and Non-Linear Cardiotoxicity in Hodgkin Lymphoma Survivors

Haroon Alamy

Poster Presenter: Haroon Alamy

Thumbnail for Second Primary Malignancy Risk Among Survivors of Classical Hodgkin Lymphoma in the Pre- and Post-PD-1 Inhibitor Era

HL - 1463

Second Primary Malignancy Risk Among Survivors of Classical Hodgkin Lymphoma in the Pre- and Post-PD-1 Inhibitor Era

Olanipekun Lanny Ntukidem

Poster Presenter: Olanipekun Lanny Ntukidem

Thumbnail for Association of Immune Checkpoint Inhibitors (ICIs) With Sarcoidosis: Analysis of the FDA Adverse Event Reporting System (FAERS)

HL - 1484

Association of Immune Checkpoint Inhibitors (ICIs) With Sarcoidosis: Analysis of the FDA Adverse Event Reporting System (FAERS)

Arifa Bibi

Poster Presenter: Arifa Bibi

ePosters in

Topics Sessions

Acute Lymphoblastic Leukemia (ALL)(71)Acute Myeloid Leukemia (AML)(230)Aggressive B-Cell Lymphoma (ABCL)(114)Cellular Therapy (CT)(128)Chronic Lymphocytic Leukemia (CLL)(110)Chronic Myeloid Leukemia (CML)(55)Hodgkin Lymphoma (HL)(54)Indolent B-Cell Lymphoma (IBCL)(47)Mantle Cell Lymphoma (MCL)(23)Multiple Myeloma (MM)(234)

Previous 1 2 Next

Sponsors